By: University of Cincinnati Cancer Center

• Tags:
• Survivorship Grant,

By: University of Cincinnati Cancer Center

Tammy Mentzel, MPH, has been named Executive Director for Center Administration and Associate Director for Administration at the University of Cincinnati Cancer Center.

• Tags:
• Cancer Center,
• Cancer Leadership,

By: University of Cincinnati Cancer Center

Andrew Waters, PhD, a basic scientist at the University of Cincinnati Cancer Center and assistant professor within the Division of Surgical Oncology and the Department of Cancer Biology at UC, runs a research lab focusing on the molecular consequences and resistance mechanisms to KRAS inhibitors.

• Tags:
• Cancer Center,
• Clinical Trials,
• Pancreatic Cancer,

By: University of Cincinnati Cancer Center

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to study the efficacy of LN-145 on patients with advanced lung cancer. This treatment involves the infusion of patients’ own immune cells, tumor-infiltrating lymphocytes (TIL), to evaluate the efficacy of LN-145 as determined by objective response rates (ORR).

• Tags:
• Cancer Research,
• Clinical Trial,

By: University of Cincinnati Cancer Center

How will the explosion of AI impact cancer research and care? Last month, the University of Cincinnati Cancer Center held the tenth annual Charge Against Cancer Symposium on “Leveraging Artificial Intelligence and Data Sciences to Conquer Cancer” to tackle this topic.

• Tags:
• Cancer Center Event,
• Cancer Research,
• Professional Development,

By: University of Cincinnati Cancer Center

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to compare a lower-than-standard dosage of a widely used treatment in newly diagnosed acute myeloid leukemia (AML) patients. This clinical trial is designed to evaluate the efficacy this dosage and treatment schedule of Venetoclax plus Azacitidine may have for newly diagnosed AML patients.

• Tags:
• Cancer Research,
• Clinical Trial,

By: University of Cincinnati Cancer Center

• Tags:
• Cancer Research,
• Event,
• Professional Development,

By: University of Cincinnati Cancer Center

• Tags:
• Breast Cancer,
• Clinical Trials,
• Exercise,
• Vascular Aging,

By: University of Cincinnati Cancer Center

• Tags:
• Grants,
• Pilot Grants,

By: University of Cincinnati Cancer Center

• Tags:
• awards,
• Endocrine,
• Thyroid Cancer,

By: University of Cincinnati Cancer Center

• Tags:
• Brain Cancer,
• Cancer Center,
• Clinical Trials,
• Immunotherapy,

By: University of Cincinnati Cancer Center

• Tags:
• Cancer Center,
• Grants,
• Survivorship,

By: University of Cincinnati Cancer Center

• Tags:
• Cancer Center,
• Clinical Trials,
• Immunotherapy,
• Liver Cancer,

By: University of Cincinnati Cancer Center

• Tags:
• Cancer Center,
• Clinical Trials,
• Head & Neck Cancer,

By: University of Cincinnati Cancer Center

• Tags:

By: University of Cincinnati Cancer Center

• Tags:
• CRTEC,

By: Karen Bankston, PhD, MSN

Black people have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers. An underlying source of health disparities among people of color is structural racism, which is defined as discrimination perpetuated through interconnected institutions and reinforced through culture, history, ideology, and sanctioned practices.

• Tags:
• Community Outreach,
• DEI,